Atlas Venture
http://www.atlasventure.com/Atlas Venture is a venture capital firm that invests in early stage technology and life sciences businesses. Since the firm’s founding in 1980, the firm has helped build over three hundred companies. Since 1995, forty seven of its investments have been acquired and more than forty have gone public, with an aggregate market capitalization of over $20 billion.
View Older Stories View More Recent Stories
-
JenaValve Technology Appoints Janet M. Fauls As Vice President Of Regulatory Affairs
-
Rodin Therapeutics, Biogen (BIIB) Enter R&D Pact Focused on Neuronal Epigenetics
-
Quartet Medicine Announces Strategic Partnership with Merck
-
Rodin Announces New Equity Financing and R&D Collaboration with Biogen
-
Synlogic to Present at the 34th Annual J.P. Morgan Healthcare Conference
-
Padlock Therapeutics Creates West Coast Operations Appointing Scientific Co-founder Kerri Mowen, Ph.D., as Director of Biology Based in San Diego
-
Rodin Therapeutics Appoints Samantha Singer to Board of Directors
-
Navitor Pharmaceuticals Announces $33 Million Series B Financing
-
Evotec and Spero Therapeutics Extend Collaboration to Develop Novel Antibacterials
-
SaltDNA Secures the Conversation: Launches First Encrypted Mobile Communications Solution Built for the Enterprise
-
OYO Sports Launches New Hockey Rinks for all 30 National Hockey League Teams
-
JenaValve Announces Certification of New Transcatheter Heart Valve Manufacturing Facility
-
miRagen Therapeutics Secures $41 million Series C Financing to Advance Two MicroRNA Programs into Clinical Trials
-
Padlock Therapeutics Appoints Adelene Perkins to Board of Directors
-
Luc Therapeutics Announces License and Collaboration Agreement to Accelerate Development of Its Program for the Treatment of Depression
-
SoapBox Secures $3M to Power "The High Performance Workforce"
-
SoapBox Secures $3M to Power "The High Performance Workforce"
-
OYO Sports Names Scott Healy new President and Chief Executive Officer
-
Navitor Pharmaceuticals’ Scientific Founder Makes Landmark Discovery of the Molecular Sensor for the Amino Acid Leucine
-
Quartet Medicine Completes $23.25 Million Series A Financing
-
Rodin Therapeutics Appoints Adam J. Rosenberg as Chief Executive Officer
-
Padlock Therapeutics Named by FierceBiotech as a 2015 “Fierce 15” Biotech Company
-
Replimune Ltd Raises $30 Million Series A Financing
-
Synlogic Accelerates Business Growth with Appointment of President, Expansion of Financing, and an Industry Collaboration
-
Best of Boston biotech startups win recognition at BioPharm America™ 2015 during Johnson & Johnson Innovation Startup Day competition
-
EBD Group to announce the Johnson & Johnson Innovation Startup Day competition grand prize winner at BioPharm America™ 2015 Partnering Event
-
Appcito Introduces Application Delivery Services for VMware-Based Enterprise Clouds
-
Navitor Pharmaceuticals Appoints David M. Madden to Board of Directors and Michael N. Hall, PhD, to Scientific Advisory Board
-
Intellia Therapeutics Secures $70 Million in Series B Financing
-
Mobee Closes $5M Series A Financing
-
AppInside Funded to Secure Mobile Apps and Protect Their Users
-
Skillz Showcases Live Events Platform At Casual Connect USA
-
JenaValve Receives $26.5 Million Financing
-
JenaValve Appoints Peter C. Wulff as Chief Financial Officer
-
Integral Ad Science Raises $67 Million to Fund Advancements in Technology and Further Global Expansion
-
LTG Exam Receives Additional Strategic Investment for Seed Funding, Brings Total to $3.6 Million
-
DraftKings Secures $300MM In Funding From All-Star Lineup
-
RaNA Therapeutics Secures $55 Million in Oversubscribed Series B Financing
-
LexShares Extends Litigation Funding Opportunities to Institutional Investors
-
Appcito Introduces Application Delivery Solution For Microsoft Azure Cloud
-
Skillz Introduces Live Events Platform Allowing Anyone to Organize and Host eSports Competitions
-
Influitive Raises $30.5M in Series B Round
-
ITeos Therapeutics Announces Appointment of Dr. Bruno Montanari to the Company's Board of Directors
-
Quartet Medicine Announces Neuron Publication Validating Role of the BH4 Pathway in Chronic Neuropathic and Inflammatory Pain
-
Navitor Pharmaceuticals Appoints Paul Friedman, MD, to Its Board of Directors
-
Synlogic to Present at Several Upcoming Scientific and Industry Conferences
-
Unum Therapeutics Announces $65 Million Series B Financing Round
-
Spero Completes $30 Million Financing
-
Skillz Pays Out $10 Million in eSports Prizes
-
JenaValve Appoints Victoria E. Carr-Brendel, Ph.D., as Chief Executive Officer

